ADC Therapeutics ADCT Cash Flow Statement (2020-2026)

NYSE ADCT
$0.96 -0.07 (-6.80%)
At close: Aug 20, 2026 · 4:00 PM EDT
Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-71.55M-35.52M-16.66M-64.37M-50.61M-18.15M-59.43M-48.20M-45.30M-46.00M-35.95M-43.71M-38.60M-56.65M-40.97M-32.97M-16.57M
Depreciation and Depletion (Quarter)
0.26M0.27M0.32M0.34M0.33M0.33M0.34M0.34M0.34M0.36M
Share-based Compensation (Quarter)
14.80M13.46M13.40M13.82M14.56M7.54M8.07M1.12M2.08M2.22M0.16M1.99M2.81M1.62M2.42M1.81M2.00M0.67M2.44M4.55M
Deferred Taxes (Quarter)
-0.07M-5.10M-0.58M42.85M
Gains from Investment Securities (Quarter)
-0.62M-0.02M-0.14M0.28M3.07M2.23M-1.13M-0.00M-2.23M-14.40M
Asset Writedowns and Impairment (Quarter)
1.94M-0.54M0.05M0.73M0.83M0.75M0.29M0.48M1.25M0.39M0.24M0.41M1.47M0.17M
Cash from Operations (Quarter)
-58.59M-61.63M-33.88M-53.01M2.19M-53.61M-15.39M-34.99M-36.67M-31.63M-44.09M-32.84M-25.04M-21.85M-56.33M-24.09M-29.63M-31.12M-29.71M-11.81M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.03M0.03M0.03M0.03M0.03M0.03M0.05M0.05M0.05M
Amortization of Deferred Charges (Quarter)
0.46M0.54M0.57M0.51M0.51M0.44M0.52M0.45M0.46M0.65M0.73M0.25M0.23M0.94M
Depreciation & Amortization (CF) (Quarter)
0.26M0.27M0.32M0.34M0.33M0.33M0.34M0.34M0.34M0.36M
Change in Working Capital
Change in Receivables (Quarter)
-13.82M-14.32M3.47M5.89M-2.42M35.82M-48.90M-0.19M-2.70M4.00M-2.00M-0.32M1.26M-3.71M11.45M-5.58M-3.27M6.19M1.93M-3.01M
Change in Inventory (Quarter)
0.35M2.05M3.48M-0.17M0.57M-0.52M0.88M2.80M0.31M0.71M0.52M0.85M-0.02M3.29M
Change in Account Payables (Quarter)
-3.93M1.74M4.38M-3.41M-1.38M0.72M-3.66M2.98M-2.71M6.57M-1.25M-4.84M4.87M3.68M-2.46M-6.22M-1.29M0.93M-3.87M7.47M
Change in Accured Expenses (Quarter)
-12.30M-3.29M-0.52M1.96M-3.54M-2.19M5.57M11.30M-20.63M12.04M-0.80M1.97M-3.18M3.82M
Change in Taxes (Quarter)
0.06M0.08M
Other Working Capital Changes (Quarter)
0.01M-5.40M-0.35M-3.93M-1.86M17.61M-0.64M-4.29M-1.31M-1.04M0.42M0.44M1.20M-0.57M-3.86M-3.19M1.60M0.21M-2.01M-0.25M
Investing Activities
Capital Expenditures (Quarter)
1.41M0.42M0.23M0.05M0.19M0.21M1.02M1.21M0.66M0.33M0.53M0.03M0.22M0.09M0.26M0.03M
Cash from Investing Activities (Quarter)
-2.34M-0.83M-1.45M-0.69M-0.25M1.70M-1.02M-1.21M-0.66M-0.33M-0.53M-0.03M-0.22M-0.09M-0.26M0.66M-0.03M
Financing Activities
Other financing activities (Quarter)
0.42M0.35M-0.00M0.32M36.60M0.27M50.49M14.61M0.20M0.12M
Cash from Financing Activities (Quarter)
219.30M-1.22M-0.26M-0.25M2.37M-2.75M0.42M73.10M0.35M-0.00M0.36M98.70M-0.88M-1.12M0.27M93.78M-0.20M57.09M-0.58M-0.10M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
-1.23M43.24M43.52M-0.02M
Additional items
Exchange Rate Effect (Quarter)
-0.07M0.03M-0.08M-0.14M-0.22M0.24M0.09M0.06M-0.12M0.15M-0.04M0.01M0.29M-0.34M0.16M0.16M0.01M-0.03M-0.01M0.01M
Change in Cash (Quarter)
158.38M-63.68M-35.59M-53.95M4.31M-54.66M-15.98M36.90M-36.98M-31.96M-44.27M65.82M-26.14M-23.06M-56.33M69.70M-29.83M26.62M-30.32M-11.91M
Free Cash Flow (Quarter)
-59.99M-62.05M-34.11M-53.06M2.00M-53.83M-16.41M-36.20M-37.33M-31.96M-44.63M-32.88M-25.26M-21.94M-56.60M-24.09M-29.63M-31.12M-29.74M-11.81M
Net Cash Flow (Quarter)
158.38M-63.68M-35.59M-53.95M4.31M-54.66M-15.98M36.90M-36.98M-31.96M-44.27M65.82M-26.14M-23.06M-56.33M69.70M-29.83M26.62M-30.32M-11.91M